1 us investigator meeting dias-4, chicago, july 2011 good clinical practice (gcp) for investigators...

22
1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

Upload: danielle-kelly

Post on 26-Mar-2015

217 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

1 US Investigator Meeting DIAS-4, Chicago, July 2011

Good Clinical Practice(GCP)

for Investigators and the Research Team

Page 2: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

2US Investigator Meeting DIAS-4, Chicago, July 2011

What kind of audit findings

1. Lack of information in medical record

2. Enrolment of patients who violate the exclusion or do not fulfil the inclusion criteria

3. Unreported AEs in the CRF

4. Lack of time for the Principal Investigator to perform the trial

5. Investigator signed Informed Consent before the patient

6. Failure of the site to complete and maintain the IMP records

Page 3: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

3US Investigator Meeting DIAS-4, Chicago, July 2011

GCP ensures that:

Patients rights, safety, and well-being are protected

Clinical trials are based on good science, are well designed and properly analysed

The study procedures are properly undertaken and documented

Why follow GCP?

If GCP is not followed:

The patients could be exposed to unnecessary risks

The data collected may be unreliable

The clinical trial can be rejected

Page 4: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

4US Investigator Meeting DIAS-4, Chicago, July 2011

Agenda

GCP responsibility for Investigator and Research team

The 12 Golden GCP rules

Question & answer

Page 5: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

5US Investigator Meeting DIAS-4, Chicago, July 2011

Rule number 1

Know and Follow the Study Protocol

Read it

Agree it

Sign it

Follow It

Make it available

File it

Page 6: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

6US Investigator Meeting DIAS-4, Chicago, July 2011

Rule number 2

Select, train and log your study personnel

Investigators’ CVs

Keep people informed

Log of study personnel

Page 7: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

7US Investigator Meeting DIAS-4, Chicago, July 2011

Example of the Log of Study Personnel

Example

Name (capital letters)

Trial Function* (capital letters)

Trial related duties* (Insert

numbers)

Signature

Initial & Date (short

signature)

PI Initial &

Date (for approval)

Stop date Only if before

closeout

DR. J OHN BROWN

PRINCIPAL INVESTIGATOR

N/A N/A

FLORENCE NI GHTI NGALE

STUDY NURSE

2 7, 8, 9

* Items listed in bold can only be performed by a physician

(1) EC/IRB communication (4) History (med, psych, neurol) (7) Vital signs, height (2) Oral Informed Consent (5) Demographics, height (8) Biochemistry/haematology (3) Obtain Written Informed Consent (6) Physic/Neurol Examination (9) Record ECG

Page 8: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

8US Investigator Meeting DIAS-4, Chicago, July 2011

Rule number 3

Record Data Carefully

Complete… timely, correctly, all required data

Avoid… missing data

Date and initial (we use eCRF: PASSWORD)…

Page 9: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

9US Investigator Meeting DIAS-4, Chicago, July 2011

Rule number 4

Ensure that you study equipments are adequate

Suitable…

Calibrated and Checked…

Available…

Maintained…

= SCAM

Page 10: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

10US Investigator Meeting DIAS-4, Chicago, July 2011

Rule number 5

Maximise your patients’ protection

IRB approval

Informed Consent (IC)

Page 11: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

11US Investigator Meeting DIAS-4, Chicago, July 2011

Patient and investigator signed on the respective

part of the IC but did not date and time.

The study coordinator noticed this and dated it on behalf of the investigator and the patient.

Is this correct according to GCP?

Case 1 - Consent

No, this is non-compliant with GCP – Investigator and

patient (or witness or legal representative) must personally sign and date and time the informed consent.

Page 12: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

12US Investigator Meeting DIAS-4, Chicago, July 2011

Can a study coordinator take informed consent?

Case 2 - Consent

In Lundbeck studies, the study coordinator can take part in the discussion with the patient about the study and

the patient information sheet

- but the investigator must always be involved and only

the investigator can obtain the Informed Consent.

Page 13: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

13US Investigator Meeting DIAS-4, Chicago, July 2011

Rule number 6

Predict accurately and log your patient

recruitment

Select the right patients (in and exclusion criteria)

If a patient decides to withdraw try to obtain and record the reason if possible

Keep the patients listed in logs

Page 14: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

14US Investigator Meeting DIAS-4, Chicago, July 2011

Rule number 7

Thorough documentation of study drug flow

Storage at site according to requirements

Document receipt, administration, storage, and return of study drug

If IMP was stored outside temperature limits – even for a minimum period of time – contact your monitor immediately

Page 15: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

15US Investigator Meeting DIAS-4, Chicago, July 2011

Rule number 8

Ensure timely and efficient safety reporting

Adverse Event (AE)

Serious Adverse Event (SAE)

Page 16: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

16US Investigator Meeting DIAS-4, Chicago, July 2011

Rule number 9

Ensure the quality of laboratory evaluations

Laboratory results and requests

CT or MRI scan

Page 17: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

17US Investigator Meeting DIAS-4, Chicago, July 2011

Rule number 10

Maintain good trial files and archives

’If it is not documented, it doesn't exist’!

Storage of the documentation

Page 18: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

18US Investigator Meeting DIAS-4, Chicago, July 2011

Rule number 11

Maximise data quality

Monitoring by CRA

Medical notes

Source Data Identification form

Page 19: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

19US Investigator Meeting DIAS-4, Chicago, July 2011

Source Document Identification

Date and result of: CRF

Patients medical record/notes

Other source - please specify

(e.g. nurse’s notes)

Patient identification

Date of visit

Informed Consent

Please complete the form by marking (one tick) where of the clinical trial data will be entered first

X

X

X

Page 20: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

20US Investigator Meeting DIAS-4, Chicago, July 2011

Rule number 12

Keep everyone fully informed

Patient andCaregiver

EC

Sponsor

SAE reporting

Study research team

CRA

Page 21: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

21US Investigator Meeting DIAS-4, Chicago, July 2011

GCP ensures that:

Patients rights, safety, and well-being are protected

Clinical trials are based on good science, are well designed and properly analysed

The study procedures are properly undertaken and documented

Keep the number of audits findings down

Q and A

Page 22: 1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team

22US Investigator Meeting DIAS-4, Chicago, July 2011

GCP Definitions

Gun Control Panel Gateway Control Protocol

God’s Child Project

Grand Central Partnership

Great Circus Parade

Ground Control Position

Ground Control Planning

Green City Project

Great-Circle Path

Grand Central Parkway

Thank you!

Good Clinical Practice